Skip to main content
logo
ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.69
+0.06 (1.07%)
Aug 7, 2026, 4:00 PM EDT - Market closed

ImageneBio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
00.83.59.1615.6230.99
Revenue Growth
--77.14%-61.79%-41.35%-49.59%237.01%
Gross Profit
00.83.59.1615.6230.99
Operating Income
-58.96-48.45-37-75.42-70.9-34.14
Net Income
-53.33-52.4-48.38-68.17-68.77-34.12
Earnings Per Share
-4.15-9.64-22.10-19.60-22.80-14.64
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
136.15135.3512.12175.47156.95232.22
Total Debt
1.912.988.0510.745.696.99
Net Cash (Debt)
134.24132.374.07164.73151.25225.23
Net Cash Growth
49.21%3152.43%-97.53%8.91%-32.84%38.77%
Net Cash Per Share
12.2227.180.8447.3650.1696.58

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-52.59-47.84-21.32-79.74-74.11-60.25
Capital Expenditures
----0.41-1.43-1.76
Free Cash Flow
-52.59-47.84-21.32-80.16-75.54-62.01
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%100.00%100.00%100.00%100.00%
Operating Margin
--6056.37%-1057.14%-823.33%-453.99%-110.18%
Pretax Margin
--5712.38%-1044.43%-745.94%-440.29%-110.10%
Profit Margin
--5668.63%-1044.80%-744.17%-440.29%-110.10%
FCF Margin
--5980.50%-609.11%-875.08%-483.67%-200.14%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-96.4413.522.536.1814.56